Long term (current) drug therapy Z79-

New Call-to-action
Code Also
Code Also Help
A code also note instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter.
  • any therapeutic drug level monitoring (
    ICD-10-CM Diagnosis Code Z51.81

    Encounter for therapeutic drug level monitoring

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Code Also
    • any long-term (current) drug therapy (Z79.-)
    Type 1 Excludes
    • encounter for blood-drug test for administrative or medicolegal reasons (Z02.83)
    Z51.81
    )
Type 2 Excludes
Type 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (Z79) and the excluded code together.
  • drug abuse and dependence (
    ICD-10-CM Diagnosis Code F11

    Opioid related disorders

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    F11
    -
    ICD-10-CM Diagnosis Code F19

    Other psychoactive substance related disorders

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Includes
    • polysubstance drug use (indiscriminate drug use)
    F19
    )
  • drug use complicating pregnancy, childbirth, and the puerperium (
    ICD-10-CM Diagnosis Code O99.32

    Drug use complicating pregnancy, childbirth, and the puerperium

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Use Additional
    • code(s) from F11-F16 and F18-F19 to identify manifestations of the drug use
    O99.32-
    )
Includes
Includes Help
"Includes" further defines, or give examples of, the content of the code or category.
  • long term (current) drug use for prophylactic purposes
Codes
  • Z79 Long term (current) drug therapy
    • Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets
      • Z79.01 Long term (current) use of anticoagulants
      • Z79.02 Long term (current) use of antithrombotics/antiplatelets
    • Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID)
    • Z79.2 Long term (current) use of antibiotics
    • Z79.3 Long term (current) use of hormonal contraceptives
    • Z79.4 Long term (current) use of insulin
    • Z79.5 Long term (current) use of steroids
      • Z79.51 Long term (current) use of inhaled steroids
      • Z79.52 Long term (current) use of systemic steroids
    • Z79.6 Long term (current) use of immunomodulators and immunosuppressants
      • Z79.60 Long term (current) use of unspecified immunomodulators and immunosuppressants
      • Z79.61 Long term (current) use of immunomodulator
      • Z79.62 Long term (current) use of immunosuppressant
        • Z79.620 Long term (current) use of immunosuppressive biologic
        • Z79.621 Long term (current) use of calcineurin inhibitor
        • Z79.622 Long term (current) use of Janus kinase inhibitor
        • Z79.623 Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
        • Z79.624 Long term (current) use of inhibitors of nucleotide synthesis
      • Z79.63 Long term (current) use of chemotherapeutic agent
        • Z79.630 Long term (current) use of alkylating agent
        • Z79.631 Long term (current) use of antimetabolite agent
        • Z79.632 Long term (current) use of antitumor antibiotic
        • Z79.633 Long term (current) use of mitotic inhibitor
        • Z79.634 Long term (current) use of topoisomerase inhibitor
      • Z79.64 Long term (current) use of myelosuppressive agent
      • Z79.69 Long term (current) use of other immunomodulators and immunosuppressants
    • Z79.8 Other long term (current) drug therapy
      • Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels
        • Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
        • Z79.811 Long term (current) use of aromatase inhibitors
        • Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • Z79.82 Long term (current) use of aspirin
      • Z79.83 Long term (current) use of bisphosphonates
      • Z79.84 Long term (current) use of oral hypoglycemic drugs
      • Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
      • Z79.89 Other long term (current) drug therapy
        • Z79.890 Hormone replacement therapy
        • Z79.891 Long term (current) use of opiate analgesic
        • Z79.899 Other long term (current) drug therapy